Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 1
1987 1
1988 1
1990 1
1992 1
1995 1
2001 1
2003 1
2014 2
2019 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Tonneau M, Nolin-Lapalme A, Kazandjian S, Auclin E, Panasci J, Benlaifaoui M, Ponce M, Al-Saleh A, Belkaid W, Naimi S, Mihalcioiu C, Watson I, Bouin M, Miller W, Hudson M, Wong MK, Pezo RC, Turcotte S, Bélanger K, Jamal R, Oster P, Velin D, Richard C, Messaoudene M, Elkrief A, Routy B. Tonneau M, et al. Oncoimmunology. 2022 Jul 7;11(1):2096535. doi: 10.1080/2162402X.2022.2096535. eCollection 2022. Oncoimmunology. 2022. PMID: 35832043 Free PMC article.
Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
Green D, Tew KD, Hisamatsu T, Schein PS. Green D, et al. Biochem Pharmacol. 1982 May 1;31(9):1671-9. doi: 10.1016/0006-2952(82)90667-0. Biochem Pharmacol. 1982. PMID: 7104031
This ratio of DNA alkylation is comparable to the 1.3 ratio we previously reported for chlorozotocin [L. C. Panasci, D. Green and P. S. Schein, J. clin. Invest. 64, 1103 (1979)]. ...
This ratio of DNA alkylation is comparable to the 1.3 ratio we previously reported for chlorozotocin [L. C. Panasci, D. Green …
High-Intensity Interval Training for Rowing: Acute Responses in National-Level Adolescent Males.
Faelli E, Panascì M, Ferrando V, Codella R, Bisio A, Ruggeri P. Faelli E, et al. Int J Environ Res Public Health. 2022 Jul 2;19(13):8132. doi: 10.3390/ijerph19138132. Int J Environ Res Public Health. 2022. PMID: 35805789 Free PMC article.
Methods: Ten national-level adolescent male rowers (age: 15.7 0.2 years; maximal oxygen uptake (VO2max): 60.11 1.91 mLkg1min1) performed two HIIT testing sessions: short (S-HIIT) and long (L-HIIT). In S-HIIT, the rowers performed 25 reps of 30 s at 100% power at VO2max (Pm …
Methods: Ten national-level adolescent male rowers (age: 15.7 0.2 years; maximal oxygen uptake (VO2max): 60.11 1.91 mLkg1min1) performed two …
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Tonneau M, Phan K, Manem VSK, Low-Kam C, Dutil F, Kazandjian S, Vanderweyen D, Panasci J, Malo J, Coulombe F, Gagné A, Elkrief A, Belkaïd W, Di Jorio L, Orain M, Bouchard N, Muanza T, Rybicki FJ, Kafi K, Huntsman D, Joubert P, Chandelier F, Routy B. Tonneau M, et al. Front Oncol. 2023 Jul 20;13:1196414. doi: 10.3389/fonc.2023.1196414. eCollection 2023. Front Oncol. 2023. PMID: 37546399 Free PMC article.
Characterization of L-threonine and L-glutamine transport in murine P388 leukemia cells in vitro. Presence of an N-like amino acid transport system.
Lazarus P, Panasci LC. Lazarus P, et al. Biochim Biophys Acta. 1986 Apr 25;856(3):488-95. doi: 10.1016/0005-2736(86)90140-9. Biochim Biophys Acta. 1986. PMID: 3083865
The transport of L-threonine and L-glutamine into murine P388 leukemia cells has been characterized. ...Threonine transport is uninhibited by 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid and alpha-(methylamino)isobutyric acid, shows a pattern of transport similar …
The transport of L-threonine and L-glutamine into murine P388 leukemia cells has been characterized. ...Threonine transport is …
The cytolytic effect of L-2,4 diaminobutyric acid with malignant glioma cells and fibroblasts.
Panasci L, McQuillan A, Feindel W. Panasci L, et al. Cancer Chemother Pharmacol. 1988;21(2):143-4. doi: 10.1007/BF00257361. Cancer Chemother Pharmacol. 1988. PMID: 3349563
L-2,4-Diaminobutyric acid (DABA), an amino acid analogue, produced a cytolytic effect with a human glioma cell line, SKMG-1, and normal human fibroblasts. ...
L-2,4-Diaminobutyric acid (DABA), an amino acid analogue, produced a cytolytic effect with a human glioma cell line, SKMG-1, and norm …
Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents.
Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Roy R, Mitra S, Alaoui-Jamali MA. Yen L, et al. Mutat Res. 1995 Nov;337(3):179-89. doi: 10.1016/0921-8777(95)00022-c. Mutat Res. 1995. PMID: 7491121
Human breast carcinoma (MCF7-MLNr) cells resistant to the bifunctional drugs L-phenylalanine mustard (L-PAM, 5-fold resistance), mechlorethamine (9-fold), cisplatin (3-fold), and BCNU (3-fold) were used to investigate the role of DNA repair in the development of res …
Human breast carcinoma (MCF7-MLNr) cells resistant to the bifunctional drugs L-phenylalanine mustard (L-PAM, 5-fold resistance …
18 results